Ignite Creation Date:
2024-05-06 @ 12:24 AM
Last Modification Date:
2024-10-26 @ 10:49 AM
Study NCT ID:
NCT01561911
Status:
COMPLETED
Last Update Posted:
2014-12-02
First Post:
2012-03-21
Brief Title:
A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 74 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment
Sponsor:
Cancer Research UK
Organization:
Cancer Research UK
Organization Data
Organization:
Cancer Research UK
Class:
OTHER
Study ID:
PH1103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cancer Research UK
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None